Risk Factors for the Development of Primary Cutaneous Melanoma

Dermatologic Clinics

Volumn 30, Issue 3, 2012, Pages 363-368

  Russak, Julie E ^a   Rigel, Darrell S ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Melanoma; Nevi; UV radiation; UV tanning

Indexed keywords

ACTINIC KERATOSIS; AGE DISTRIBUTION; BEHAVIOR CHANGE; BLISTER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; DERMATOLOGICAL PROCEDURE; ETHNIC DIFFERENCE; FAMILY HISTORY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEALTH CARE ACCESS; HEALTH EDUCATION; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; INDOOR TANNING; MELANOCYTIC NEVUS; MELANOMA SKIN CANCER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RACE DIFFERENCE; RADIATION EXPOSURE; REVIEW; SEX DIFFERENCE; SKIN EXAMINATION; SOCIAL STATUS; SUN EXPOSURE; SUNBURN; TREND STUDY; ULTRAVIOLET RADIATION; UNITED STATES;

EARLY DETECTION OF CANCER; HUMANS; INCIDENCE; MELANOMA; NEVUS; RISK FACTORS; SEX FACTORS; SKIN NEOPLASMS; SUNBATHING; SUNLIGHT; SURVIVAL RATE; UNITED STATES;

EID: 84863857967     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2012.05.002     Document Type: Review

References (52)

1. Linos E., Swetter S.M., Cockburn M.G., et al. Increasing burden of melanoma in the United States. J Invest Dermatol 2009, 129:1666-1674.
2. Available at: Accessed April 30, 2012. http://seer.cancer.gov/csr/1975_2006/.
3. Jemal A., Siegel R., Ward E., et al. Cancer Statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
4. Kopf A.W., Rigel D.S., Friedman R.J. The rising incidence and mortality rate of malignant melanoma. J Dermatol Surg Oncol 1982, 8:760-761.
5. Albert M.R., Weinstock M.A. Keratinocyte carcinoma. CA Cancer J Clin 2003, 53:292-302.
6. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 2007, 57(1):43-66.
7. Siegel R., Naihadsham M.A., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62(1):43-66.
8. Ouhtit A., Nakazawa H., Armstrong B.K., et al. UV-Radiation-Specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma. J Natl Cancer Inst 1998, 90:523-531.
9. Setlow R.B., Grist E., Thompson K., et al. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci U S A 1993, 90:6666-6670.
10. Ley R.D. Dose response for ultraviolet radiation A-induced focal melanocytic hyperplasia and nonmelanoma skin tumors in Monodelphis domestica. Photochem Photobiol 2001, 73:20-23.
11. Markovic S.N., Erickson L.A., Rao R.D., et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007, 82(3):364-380.
12. Armstrong B.K., Kricker A. Epidemiology of skin cancer. Photochem Photobiol 2001, 63:8-18.
13. Moan J., Dahlback A., Setlow A.B. Epidemiological support for an hypothesis for melanoma induction indicating a role for UVA radiation. Photochem Photobiol 1999, 70:243-247.
14. Rigel D.S., Rigel E.G., Rigel A.C. Effects of altitude and latitude on ambient UVB radiation. J Am Acad Dermatol 1999, 40(1):114-116.
15. Fears T.R., Bird C.C., Guerry D., et al. Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk. Cancer Res 2002, 62(14):3992-3996.
16. Levine J.A., Sorace M., Spencer J., et al. The indoor UV tanning industry: a review of skin cancer risk, health benefit claims, and regulation. J Am Acad Dermatol 2005, 53(6):1038-1044.
17. Swerdlow A.J., Weinstock M.A. Do tanning lamps cause melanoma? An epidemiologic assessment. J Am Acad Dermatol 1998, 38(1):89-98.
18. Westerdahl J., Ingvar C., Masback A., et al. Risk of cutaneous melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity. Br J Cancer 2000, 82(9):1593-1599.
19. Ting W., Schultz K., Cac N.N., et al. Tanning bed exposure increases the risk of malignant melanoma. Int J Dermatol 2007, 46(12):1253-1257.
20. International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer 2007, 120(5):1116-1122.
21. Diffey B.L. A quantitative estimate of melanoma mortality from ultraviolet A sunbed use in the U.K. Br J Dermatol 2003, 149(3):578-581.
22. Snels D.G., Hille E.T., Gruis N.A., et al. Risk of cutaneous malignant melanoma in patients with nonfamilial atypical nevi from a pigmented lesions clinic. J Am Acad Dermatol 1999, 40(5 Pt 1):686-693.
23. Tucker M.A. Melanoma epidemiology. Hematol Oncol Clin North Am 2009, 23(3):383-395. vii.
24. Gandini S., Sera F., Cattaruzza M.S., et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 2005, 41(1):28-44.
25. Marks R. Epidemiology of melanoma. Clin Exp Dermatol 2000, 25(6):459-463.
26. Green A., Williams G., Neale R., et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999, 354:723-729.
27. Naylor M.F., Boyd A., Smith D.W., et al. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol 1995, 131:170-175.
28. MacLennan R., Kelly J.W., Rivers J.K., et al. The Eastern Australian Childhood Nevus Study: site differences in density and size of melanocytic nevi in relation to latitude and phenotype. J Am Acad Dermatol 2003, 48(3):367-375.
29. Florell S.R., Boucher K.M., Garibotti G., et al. Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol 2005, 23:7168-7177.
30. Tucker M.A., Boice J.D., Hoffman D.A. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985, 68:161-189.
31. Kang S., Barnhill R.L., Mihm M.C., et al. Multiple primary cutaneous melanomas. Cancer 1992, 70:1911-1916.
32. DiFronzo L.A., Wanek L.A., Elashoff R., et al. Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Ann Surg Oncol 1999, 6:705-711.
33. Goggins W.B., Tsao H. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors. Cancer 2003, 97(3):639-643.
34. Norris W. Case of fungoid disease. Edinb Med Surg J 1820, 16:562-565.
35. Lynch H.T., Krush A.J. Hereditary and malignant melanoma: implications for early cancer detection. Can Med Assoc J 1968, 99:789-792.
36. Clark W.H., Reimer R.R., Greene M., et al. Origin of familial malignant melanomas from heritable melanocytic lesions: the B-K mole syndrome. Arch Dermatol 1978, 114(5):732-738.
37. Meyer K., Guldberg P. Genetic risk factors for melanoma. Hum Genet 2009, 120:499-510.
38. Begg C.B., Orlow I., Hummer A.J., et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst 2005, 97:1507-1515.
39. Suzuki I., Cone R.D., Im S., et al. Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 1996, 137:1627-1633.
40. Valverde P., Healy E., Jackson I., et al. Variants of the melanocyte stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 1995, 11:328-330.
41. Box N.F., Duff y D.L., Chen W., et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 2001, 69:765-773.
42. Lin J.Y., Fisher D.E. Melanocyte biology and skin pigmentation. Nature 2007, 445:843-850.
43. Available at: Accessed September 1, 2010. http://seer.cancer.gov/statfacts/html/melan.html#incidence-mortality.
44. Fast Stats: an interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute. Available at: Accessed September 3, 2010. http://seer.cancer.gov/faststats.
45. Eide M.J., Weinstock M.A. Epidemiology of skin cancer. Cancer of the skin 2011, Elevier, Philadelphia. D.S. Rigel (Ed.).
46. Pollitt R.A., Clarke C.A., Swetter S.M., et al. The expanding melanoma burden in California hispanics: importance of socioeconomic distribution, histologic subtype, and anatomic location. Cancer 2011, 117(1):152-161.
47. Available at: Accessed September 01, 2010. http://seer.cancer.gov/faststats/selections.php?#Output.
48. MacKie R.M., Hole D.J. Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status. BMJ 1996, 312(7039):1125-1128.
49. Eide M.J., Weinstock M.A., Clark M.A. Demographic and socioeconomic predictors of melanoma prognosis in the United States. J Health Care Poor Underserved 2009, 20(1):227-245.
50. Bates M.N. Registry-based case-control study of cancer in California firefighters. Am J Ind Med 2007, 50(5):339-344.
51. Vågerö D., Swerdlow A.J., Beral V. Occupation and malignant melanoma: a study based on cancer registration data in England and Wales and in Sweden. Br J Ind Med 1990, 47(5):317-324.
52. Goldberg M.S., Doucette J.T., Lim H.W., et al. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005. J Am Acad Dermatol 2007, 57(1):60-66.